Back to top of page

Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)

- Detailed description of the project goals and objectives

- Explanation of how the project will use genome or epigenome editing techniques

- Identification of the specific genes or variants that will be targeted for validation and characterization

- Justification for why these genes or variants are relevant to substance use disorders

- Plan for generating and sharing genetic resources with the scientific community

- Overview of the methods and approaches that will be used for functional validation and characterization

- Description of the substance use disorder-relevant phenotypes that will be investigated

- Explanation of how the project findings will advance understanding of the neurobiological mechanisms involved

- Discussion of the potential impact of the project on future prevention, diagnostic, and therapeutic strategies for substance use disorders

- Timeline for project completion and any milestones that will be achieved

- Budget breakdown and justification for requested funds

- Summary of the team members' qualifications and expertise relevant to the project

- Statement on the ethical considerations and potential risks associated with genome or epigenome editing research

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows